Argatroban and Lepirudin: Clinical Trials to Clinical Practice

Hirsh J , Heddle N , Kelton J. Treatment of heparin-induced thrombocytopenia, a critical review. Arch Intern Med 2004;164:361.

Warkentin TE . Management of heparin induced thrombocytopenia: A critical comparison of lepirudin and argatroban. Thromb Res 2003;110:73.

Greinacher A , Volpel H , Janssens V , et al. Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia, a prospective study. Circulation 1999;99:73.

Greinacher A , Janssens U , Berg G. Lepirudin (recombinant hirudin) for parenteral anticoagulation in patients with heparin-induced thrombocytopenia. Circulation 1999;100:587.

Lubenow N , Eichler P , Lietz T , et al. Lepirudin for prophylaxis of thrombosis in patients with acute isolated heparin-induced thrombocytopenia: An analysis of 3 prospective studies. Blood 2004;104:3072.

Physicians’ Desk Reference. 59th Edition. Montvale, NJ: Thomson PDR; 2005.

Warkentin TE , Greinacher A. Heparin-induced thrombocytopenia: Recognition, treatment, and prevention: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126(suppl):311S.

Berry CN , Girardot C , Lecoffre C , et al. Effects of the synthetic thrombin inhibitor argatroban on fibrin or clot-incorporated thrombin: Comparison with heparin and recombinant hirudin. Thromb Haemost 1994;72:381.

Zoldhelyi P , Bichler J , Owen W , et al. Persistent thrombin generation in humans during specific thrombin inhibition with hirudin. Circulation 1994;90:2671.